SIREN : 798722088
HPV is a French company founded 12 years ago, specialized in the sector Activités des sociétés holding. Based in BRUZ (35170), this company of category PME shows in 2025 a revenue of 16 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15 611 € | 17 007 € | 17 674 € | 14 340 € | 14 193 € | 13 134 € | 14 739 € | 16 139 € |
| Net income | 304 186 € | 248 069 € | 189 298 € | 146 397 € | 175 820 € | 23 079 € | 3 717 € | 50 771 € |
| EBITDA | -4 731 € | -3 627 € | -3 973 € | -3 491 € | -3 360 € | -3 454 € | -10 437 € | -2 867 € |
| Net margin | 1948.5% | 1458.6% | 1071.1% | 1020.9% | 1238.8% | 175.7% | 25.2% | 314.6% |
In 2025, HPV achieves revenue of 16 k€. Activity remains stable over the period (CAGR: -0.4%). Slight decline of -8% vs 2024. After deducting consumption (0 €), gross margin stands at 16 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -5 k€, representing -30.3% of revenue. Warning negative scissor effect: despite revenue change (-8%), EBITDA varies by -30%, reducing margin by 9.0 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 304 k€, i.e. 1948.5% of revenue. This profit can be retained or distributed to shareholders.
15 611 €
15 611 €
-4 731 €
-4 733 €
304 186 €
-30.3%
The debt ratio (= Financial debt / Equity x 100) stands at 26%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 1948.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
25.647%
77.713%
1948.536%
1.111
In 2025, the debt ratio of HPV (25.65) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of HPV (77.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2025, the repayment capacity of HPV (1.11) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 3237.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
3237.233
0.0
In 2025, the liquidity ratio of HPV (3237.23) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2025, the interest coverage of HPV (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 31 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 45 days. Favorable situation: supplier credit is longer than customer credit by 14 days. WCR is negative (-703 days): operations structurally generate cash. Notable WCR improvement over the period (-2267%), freeing up cash.
-30 488 €
31 j
45 j
0 j
-703 j
Indicative estimate only : the number of comparable transactions in this sector is limited (20 transactions). This range of 53 108€ to 1 507 018€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 20 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare HPV with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of HPV in 2025 is 16 k€.
Yes, HPV generated a net profit of 304 k€ in 2025.
The headquarters of HPV is located in BRUZ (35170), in the department Ille-et-Vilaine.
The tax return of HPV is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
HPV operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.